AstraZeneca, Cephalon Pay $54M To End Medicaid Rebate Row
AstraZeneca LP and Cephalon Inc. have agreed to pay $46.5 million and $7.5 million, respectively, to resolve claims brought by a whistleblower in a False Claims Act suit accusing the drugmakers...To view the full article, register now.
Already a subscriber? Click here to view full article